Skip to main content

Table 3 Summary of bleeding complications during treatment with immunotherapy

From: Treatment with therapeutic anticoagulation is not associated with immunotherapy response in advanced cancer patients

Outcome

Not on anticoagulation (n = 828)

On anticoagulation (n = 120)

p-value

Bleeding outcomesa

  

0.05

No. (%)

32 (3.9)

10 (8.3)

 

95% CIb

2.7–5.4

4.1–14.8

 
  1. aBleeding outcomes included major and clinically relevant minor bleeds
  2. b The 95% confidence intervals were calculated using the Clopper-Pearson method